PODD Insulet Corp

  1. Stocks
  2. Healthcare
  3. NASDAQ: PODD

Price (delayed)

$167.25

Market cap

$11.7B

P/E Ratio

56.5

Dividend/share

N/A

EPS

$2.96

Enterprise value

$12.41B

Insulet Corporation , headquartered in Massachusetts, is an innovative medical device company dedicated to simplifying life for people with diabetes and other conditions through its Omnipod product platform. The Omnipod ...

Highlights
PODD's price to earnings (P/E) is 99% lower than its last 4 quarters average of 8095.6 and 98% lower than its 5-year quarterly average of 2871.5
The EPS has soared by 72% from the previous quarter
Insulet's quick ratio has increased by 11% from the previous quarter but it has decreased by 2.1% YoY
Sector: Healthcare
Industry: Medical Devices
Website: http://www.myomnipod.com
Peers: ICUI DCTH TNDM DXCM

Key stats

What are the main financial stats of PODD
Market
Shares outstanding
69.93M
Market cap
$11.7B
Enterprise value
$12.41B
Valuations
Price to earnings (P/E)
56.5
Price to book (P/B)
15.94
Price to sales (P/S)
6.87
EV/EBIT
49.47
EV/EBITDA
38.34
EV/Sales
7.31
Earnings
Revenue
$1.7B
EBIT
$250.8M
EBITDA
$323.6M
Free cash flow
$36.5M
Per share
EPS
$2.96
Free cash flow per share
$0.52
Book value per share
$10.49
Revenue per share
$24.33
TBVPS
$34.95
Balance sheet
Total assets
$2.59B
Total liabilities
$1.86B
Debt
$1.42B
Equity
$732.7M
Working capital
$1.13B
Liquidity
Debt to equity
1.93
Current ratio
3.51
Quick ratio
2.36
Net debt/EBITDA
2.2
Margins
EBITDA margin
19.1%
Gross margin
68.3%
Net margin
12.2%
Operating margin
13%
Efficiency
Return on assets
8.5%
Return on equity
34.4%
Return on invested capital
9.7%
Return on capital employed
11.7%
Return on sales
14.8%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

PODD stock price

How has the Insulet stock price performed over time
Intraday
-0.01%
1 week
0.6%
1 month
1.79%
1 year
-47.53%
YTD
-22.92%
QTD
-2.42%

Financial performance

How have Insulet's revenue and profit performed over time
Revenue
$1.7B
Gross profit
$1.16B
Operating income
$220M
Net income
$206.3M
Gross margin
68.3%
Net margin
12.2%
PODD's net income has surged by 72% since the previous quarter
Insulet's operating income has surged by 60% QoQ
The company's net margin has surged by 58% QoQ
The company's operating margin rose by 48% QoQ

Growth

What is Insulet's growth rate over time

Valuation

What is Insulet stock price valuation
PODD P/E details
P/E
56.5
P/B
15.94
P/S
6.87
EV/EBIT
49.47
EV/EBITDA
38.34
EV/Sales
7.31
PODD's price to earnings (P/E) is 99% lower than its last 4 quarters average of 8095.6 and 98% lower than its 5-year quarterly average of 2871.5
The EPS has soared by 72% from the previous quarter
PODD's price to book (P/B) is 67% less than its 5-year quarterly average of 47.6 and 47% less than its last 4 quarters average of 29.9
The equity has soared by 54% YoY and by 21% QoQ
PODD's price to sales (P/S) is 53% lower than its 5-year quarterly average of 14.7 and 40% lower than its last 4 quarters average of 11.5
PODD's revenue is up by 30% year-on-year and by 9% since the previous quarter

Efficiency

How efficient is Insulet business performance
The return on assets has surged by 67% since the previous quarter
Insulet's return on invested capital has surged by 62% QoQ
PODD's ROE has soared by 54% QoQ
The ROS has grown by 49% from the previous quarter

Dividends

What is PODD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for PODD.

Financial health

How did Insulet financials performed over time
The total assets is 39% higher than the total liabilities
The total assets rose by 15% YoY and by 4.9% QoQ
Insulet's quick ratio has increased by 11% from the previous quarter but it has decreased by 2.1% YoY
The company's debt is 93% higher than its equity
The equity has soared by 54% YoY and by 21% QoQ
The debt to equity has decreased by 34% YoY and by 18% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.